Ascendis Pharma
Social media
Ascendis Pharma Logo
About Ascendis Pharma
Ascendis Pharma A/S is a global biopharmaceutical company headquartered in Denmark, focused on developing and commercializing innovative therapies for unmet medical needs using its TransCon technology platform. The company offers approved treatments such as SKYTROFA for pediatric growth hormone deficiency and YORVIPATH for chronic hypoparathyroidism in adults. Ascendis Pharma is advancing a pipeline of endocrinology rare disease and oncology product candidates, with research and operations across Europe and North America.
Address
Tuborg Boulevard 12,
Hellerup, 2900
Denmark
Year founded
2006
Number of employees
1,000-2,000
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
